News Financials About Visit Website Latest News Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation BioElectronics Corporation Announces Utility Patent Application Filing May. 21, 2024 8:00 AM ET BioElectronics Corporation Announces the Publication of a Canine Arthritis Study Mar. 25, 2024 8:45 AM ET BioElectronics Corporation Announces the Publication of Pilot Study Results Feb. 23, 2024 8:30 AM ET More News Financials About Contact 301-874-4890 Visit Website BioElectronics Chairman Updates Investors Feb. 15, 2024 9:00 AM ET End of Year Message From the Chairman of the Board of BioElectronics Dec. 22, 2023 3:55 PM ET BioElectronics' Chairman Discusses Recent Clinical Research Findings Jul. 22, 2022 6:00 AM ET BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group Apr. 6, 2022 6:00 AM ET BioElectronics' RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico Mar. 30, 2022 6:00 AM ET BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements Feb. 28, 2022 7:00 AM ET BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway Jan. 3, 2022 6:00 AM ET BioElectronics Corporation Reports Q3 Earnings Nov. 16, 2021 7:00 AM ET BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com Oct. 7, 2021 7:00 AM ET BioElectronics Corporation Discusses Q2 Financials Aug. 30, 2021 8:00 AM ET BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts Apr. 19, 2021 7:00 AM ET BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021 Jan. 19, 2021 8:30 AM ET BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market Dec. 15, 2020 7:25 AM ET BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx -- Drug-Free Pain Therapy Devices Nov. 12, 2020 7:00 AM ET BioElectronics Chairman Outlines New Direction for Company Aug. 10, 2020 7:30 AM ET Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation Jun. 15, 2020 9:00 AM ET BioElectronics Announces U.S. FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain Feb. 3, 2020 6:00 AM ET BioElectronics Announces New Management Team Nov. 15, 2019 6:30 AM ET BioElectronics Founder and CEO Andrew J. Whelan Has Died Suddenly Oct. 7, 2019 12:43 PM ET BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain Oct. 2, 2019 9:50 AM ET BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug Aug. 20, 2019 8:30 AM ET BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy Jul. 1, 2019 9:03 AM ET BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain Jun. 3, 2019 9:37 AM ET BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain May. 22, 2019 10:48 AM ET BioElectronics Responds to FDA's 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications Apr. 23, 2019 8:30 AM ET BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center Mar. 8, 2019 10:41 AM ET BioElectronics Files FDA Applications for Treatment of Musculoskeletal & Postoperative Pain Feb. 12, 2019 8:00 AM ET BioElectronics President's Response to Stock Price Decline Dec. 4, 2018 8:30 AM ET BioElectronics Announces FDA Market Clearance Update Nov. 27, 2018 9:34 AM ET BioElectronics Signs a Five Country Additional Distribution Agreement with Mundipharma Pty Limited, South East Asia Nov. 15, 2018 8:30 AM ET BioElectronics Announces Publication of Electroceuticals Article on Chronic Pain Oct. 4, 2018 8:30 AM ET BioElectronics Applies for FDAs Opioid Alternative Innovation Challenge Program Aug. 13, 2018 7:30 AM ET BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio Jul. 23, 2018 8:30 AM ET BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain Jul. 12, 2018 8:30 AM ET B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program May. 31, 2018 8:00 AM ET BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application May. 29, 2018 11:53 AM ET BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application May. 11, 2018 8:30 AM ET BioElectronics to Meet with FDA To Seek Expanded OTC Clearances May. 2, 2018 8:00 AM ET BioElectronics Announces Expanded Menstrual Pain Study Jan. 16, 2018 8:30 AM ET BioElectronics and CARE Pharmacies to Provide Pain Consultations and ActiPatch, the Drug Free Alternative to Opioids Jan. 9, 2018 10:11 AM ET BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage Jan. 4, 2018 7:00 AM ET BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids Dec. 12, 2017 8:30 AM ET BioElectronics Announces the Launch of the Try & Tell Program Dec. 7, 2017 8:30 AM ET BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives Nov. 13, 2017 8:30 AM ET BioElectronics to Showcase Products at World's Largest Medical Tradeshow Nov. 9, 2017 9:00 AM ET BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch) Nov. 6, 2017 10:37 AM ET BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain Oct. 16, 2017 8:30 AM ET BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy) Sep. 25, 2017 9:00 AM ET Letter from BioElectronics' (OTC PINK: BIEL) President to Investors Aug. 28, 2017 11:44 AM ET BioElectronics' President Discusses Company's Many Opportunities Aug. 22, 2017 10:00 AM ET BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing Aug. 22, 2017 8:30 AM ET BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy) Aug. 8, 2017 8:30 AM ET BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award Aug. 2, 2017 8:30 AM ET BioElectronics to Present at 2017 UK Community Pharmacists' Meeting Jun. 30, 2017 9:24 AM ET BioElectronics Announces Health Economics Study Jun. 29, 2017 11:10 AM ET BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy) May. 30, 2017 8:30 AM ET BioElectronics Expands into Tesco in the UK Market May. 17, 2017 11:35 AM ET BioElectronics to Launch Educational Strategy: ActiPatch as the First Line of Defense Against Opioid Pain Medication Apr. 18, 2017 9:41 AM ET BioElectronics to Present Research at 13th World Congress of International Neuromodulation Society Apr. 11, 2017 10:53 AM ET BioElectronics' ActiPatch Exhibits At Australia's Major Pharmaceutical Event Mar. 13, 2017 8:30 AM ET BioElectronics Appoints an Indian Subcontinent Distributor Mar. 6, 2017 9:00 AM ET BioElectronics Initiates US Over-the-Counter (Non Prescription) Sales Of Its FDA Cleared Drug-free Pain Relief Medical Devices Mar. 2, 2017 9:12 AM ET BioElectronics Corporation Letter from the President Feb. 28, 2017 9:26 AM ET BioElectronics Announces ActiPatch(R) Available on Amazon Feb. 9, 2017 9:22 AM ET BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch(R) Musculoskeletal Pain Therapy Feb. 6, 2017 9:14 AM ET
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study Mar. 25, 2024 8:45 AM ET
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group Apr. 6, 2022 6:00 AM ET
BioElectronics' RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico Mar. 30, 2022 6:00 AM ET
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements Feb. 28, 2022 7:00 AM ET
BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway Jan. 3, 2022 6:00 AM ET
BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com Oct. 7, 2021 7:00 AM ET
BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts Apr. 19, 2021 7:00 AM ET
BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021 Jan. 19, 2021 8:30 AM ET
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market Dec. 15, 2020 7:25 AM ET
BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx -- Drug-Free Pain Therapy Devices Nov. 12, 2020 7:00 AM ET
BioElectronics Announces U.S. FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain Feb. 3, 2020 6:00 AM ET
BioElectronics Announces Publication of a Study of the ActiPatch Medical Device as an Effective Long-Term Treatment for Chronic Pain Oct. 2, 2019 9:50 AM ET
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug Aug. 20, 2019 8:30 AM ET
BioElectronics Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy Jul. 1, 2019 9:03 AM ET
BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Pain Jun. 3, 2019 9:37 AM ET
BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Pain May. 22, 2019 10:48 AM ET
BioElectronics Responds to FDA's 510(k) Additional Information Requests for its Musculoskeletal Pain Relief and Postoperative Pain Applications Apr. 23, 2019 8:30 AM ET
BioElectronics Announces Back Pain Clinical Study with Leading Australian Pain Center Mar. 8, 2019 10:41 AM ET
BioElectronics Files FDA Applications for Treatment of Musculoskeletal & Postoperative Pain Feb. 12, 2019 8:00 AM ET
BioElectronics Signs a Five Country Additional Distribution Agreement with Mundipharma Pty Limited, South East Asia Nov. 15, 2018 8:30 AM ET
BioElectronics Announces Publication of Electroceuticals Article on Chronic Pain Oct. 4, 2018 8:30 AM ET
BioElectronics Applies for FDAs Opioid Alternative Innovation Challenge Program Aug. 13, 2018 7:30 AM ET
BioElectronics ActiPatch Musculoskeletal Therapy Added to Mundipharma Australia's Pain Portfolio Jul. 23, 2018 8:30 AM ET
B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program May. 31, 2018 8:00 AM ET
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application May. 29, 2018 11:53 AM ET
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application May. 11, 2018 8:30 AM ET
BioElectronics and CARE Pharmacies to Provide Pain Consultations and ActiPatch, the Drug Free Alternative to Opioids Jan. 9, 2018 10:11 AM ET
BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage Jan. 4, 2018 7:00 AM ET
BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives Nov. 13, 2017 8:30 AM ET
BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch) Nov. 6, 2017 10:37 AM ET
BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain Oct. 16, 2017 8:30 AM ET
BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy) Sep. 25, 2017 9:00 AM ET
BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing Aug. 22, 2017 8:30 AM ET
BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy) Aug. 8, 2017 8:30 AM ET
BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award Aug. 2, 2017 8:30 AM ET
BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy) May. 30, 2017 8:30 AM ET
BioElectronics to Launch Educational Strategy: ActiPatch as the First Line of Defense Against Opioid Pain Medication Apr. 18, 2017 9:41 AM ET
BioElectronics to Present Research at 13th World Congress of International Neuromodulation Society Apr. 11, 2017 10:53 AM ET
BioElectronics' ActiPatch Exhibits At Australia's Major Pharmaceutical Event Mar. 13, 2017 8:30 AM ET
BioElectronics Initiates US Over-the-Counter (Non Prescription) Sales Of Its FDA Cleared Drug-free Pain Relief Medical Devices Mar. 2, 2017 9:12 AM ET
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch(R) Musculoskeletal Pain Therapy Feb. 6, 2017 9:14 AM ET
